A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes

被引：0
|
作者：
T. Shinoda-Tagawa
Y. Yamasaki
S. Yoshida
Y. Kajimoto
T. Tsujino
N. Hakui
M. Matsumoto
M. Hori
机构：
[1] Department of Internal Medicine and Therapeutics,
[2] Osaka University Graduate School of Medicine,undefined
[3] Suita City,undefined
[4] Osaka,undefined
[5] Japan,undefined
来源：
Diabetologia | 2002年 / 45卷
关键词：
Keywords Silent brain infarction; intima-media thickness; Type II diabetes; antithrombotic drug;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：188 / 194
页数：6
相关论文
共 50 条
  • [1] A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes
    Shinoda-Tagawa, T
    Yamasaki, Y
    Yoshida, S
    Kajimoto, Y
    Tsujino, T
    Hakui, N
    Matsumoto, M
    Hori, M
    DIABETOLOGIA, 2002, 45 (02) : 188 - 194
  • [2] Relationship between carotid ultrasonography and silent cerebral infarction in Japanese subjects with Type 2 diabetes
    Nomura, Kazuhiro
    Takahara, Shiho
    Kikuchi, Osamu
    Hamamoto, Yoshiyuki
    Honjo, Sachiko
    Ikeda, Hiroki
    Nabe, Koichiro
    Wada, Yoshiharu
    Koshiyama, Hiroyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S87 - S88
  • [3] Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients
    Mitsuhashi, N
    Tanaka, Y
    Kubo, S
    Ogawa, S
    Hayashi, C
    Uchino, H
    Shimizu, T
    Watada, H
    Kawasumi, M
    Onuma, T
    Kawamori, R
    ENDOCRINE JOURNAL, 2004, 51 (06) : 545 - 550
  • [4] Effect of the Phosphodiesterase Inhibitor, Cilostazol on Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    Park, Yongsoo
    Hong, Sangmo
    Nam, Moonsuk
    Woo, Jungtaek
    DIABETES, 2016, 65 : A121 - A122
  • [5] The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus
    Hong, Sangmo
    Nam, Moon Suk
    Woo, Jeong-Taek
    Kim, Young Seol
    Baik, Sei Hyun
    Lee, Kwan Woo
    Kang, Jun Goo
    Kim, Doo-Man
    Park, Yongsoo
    DIABETES, 2014, 63 : A110 - A110
  • [6] The Phosphodiesterase Inhibitor Cilostazol Induces Regression of Carotid Atherosclerosis in Subjects With Type 2 Diabetes Mellitus Principal Results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) Study: A Randomized Trial
    Katakami, Naoto
    Kim, Young-Seol
    Kawamori, Ryuzo
    Yamasaki, Yoshimitsu
    CIRCULATION, 2010, 121 (23) : 2584 - U94
  • [7] Relationship Between Carotid Intima-Media Thickness and Silent Cerebral Infarction in Japanese Subjects With Type 2 Diabetes
    Nomura, Kazuhiro
    Hamamoto, Yoshiyuki
    Takahara, Shiho
    Kikuchi, Osamu
    Honjo, Sachiko
    Ikeda, Hiroki
    Wada, Yoshiharu
    Nabe, Koichro
    Okumra, Ryosuke
    Koshiyama, Hiroyuki
    DIABETES CARE, 2010, 33 (01) : 168 - 170
  • [8] Association between phosphodiesterase 4D gene polymorphisms and silent brain infarction in the Japanese population
    Yanai, K
    Nabika, T
    Takeuchi, F
    Nagano, S
    Kobayashi, S
    Kato, N
    JOURNAL OF HYPERTENSION, 2004, 22 : S146 - S146
  • [9] Effect of cilostazol, a phosphodiesterase III inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes
    Lee, D. -H.
    Chun, E.
    Choi, S.
    Jang, H.
    Lim, S.
    DIABETOLOGIA, 2017, 60 : S529 - S529
  • [10] Reduced ATP release from erythrocytes of humans with type 2 diabetes is increased by the phosphodiesterase 3 inhibitor cilostazol
    Sprague, R
    Stephenson, A
    Bowles, E
    Ricketts, G
    Stumpf, M
    Lonigro, A
    FASEB JOURNAL, 2006, 20 (04): : A269 - A269
12345